Naples Global Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Naples Global Advisors's NVO Position: Q2 2026 in Review
Naples Global Advisors increased its Novo Nordisk (NVO) stake by 28% in Q2 2026, buying an estimated $287K and bringing the position to 30,920 shares worth $1.48M. The position accounts for 0.09% of the portfolio, ranked #197.
Naples Global Advisors first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.66M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Naples Global Advisors held 30,920 shares of Novo Nordisk worth $1.48M as of Q2 2026.
- Naples Global Advisors bought 6,675 Novo Nordisk shares in Q2 2026, an estimated $287K.
- Novo Nordisk made up 0.09% of Naples Global Advisors's portfolio in Q2 2026, its #197 holding.
- Naples Global Advisors first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
- Naples Global Advisors's Novo Nordisk position peaked at $1.66M in Q4 2025.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.